Ambulatory Blood Pressure Monitors Market Size to Exceed USD 3,438.9 Mn by 2032

The Ambulatory Blood Pressure Monitors Market, estimated at USD 1,955.3 Mn in 2025, is expected to exhibit a CAGR of 8.4% and reach USD 3,438.9 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

Increasing research and development activities for ambulatory blood pressure monitors is expecetd to drive the global  ambulatory blood pressure monitors market growth. For instance, in July 2025, Texas A&M University researcher  Dr. Roozbeh Jafari, a professor of biomedical engineering, computer science and engineering, and electrical and computer engineering departments, and his team had received a US $3.6 million grant from the National Institutes of Health (NIH) to create a system that a user can wear all night while sleeping to provide continuous readings. Dr. Roozbeh Jafari and his team are developing a wrist-worn blood pressure system that monitors blood pressure during sleep.

Global Ambulatory Blood Pressure Monitors Market - Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic has had both positive and negative impacts on the healthcare sector:

• Increased Awareness: The pandemic has heightened awareness of the importance of monitoring vital signs, including blood pressure, at home. This could potentially lead to increased adoption of home monitoring devices, including ambulatory blood pressure monitors.
• Remote Patient Monitoring: With lockdowns and restrictions in place, there has been a greater emphasis on remote patient monitoring. Ambulatory blood pressure monitors, which allow for continuous monitoring outside of clinical settings, became more relevant during times when in-person visits were limited.
• Supply Chain Disruptions: The medical device industry, like many others, experienced disruptions in the supply chain due to lockdowns, travel restrictions, and manufacturing challenges. This could have impacted the production and distribution of ambulatory blood pressure monitors.
• Delayed Healthcare Procedures: Non-essential medical procedures and routine healthcare visits were often delayed or canceled during the height of the pandemic. This may have affected the demand for ambulatory blood pressure monitors, as they are often prescribed or recommended during routine medical check-ups.
• Economic Impact: Economic challenges during the pandemic may have influenced purchasing decisions, both by healthcare providers and individuals. Some may have postponed or scaled back on non-essential medical expenditures, affecting the market for ambulatory blood pressure monitors.

Global Ambulatory Blood Pressure Monitors Market: Key Developments

In July 2021, Biospectal, a remote patient monitoring and biosensing software company, closed a US $ 4.3 million round of seed funding led by digital health investor, SeedLink, with additional funding from LabCorp, Athensmed, Switzerland-based Privilege Ventures, and other European and U.S. investors. Biospectal will leverage the new funds to scale its OptiBP smartphone blood pressure monitoring application and data platform technology worldwide.

In August 2020,  Preventric AI, a local digital health company, announced that it had raised funding for its new device, the BPro. Preventric’s BPro is a watch-like wearable device that uses an ambulatory blood pressure monitoring (ABPM) to provide healthcare providers with 24/7 consistent blood pressure monitoring.  

In July 2020, OMRON Healthcare, Inc., a global leader in personal heart health and wellness technology, and Mount Sinai Health System, a U.S.-based largest academic medical system, had partnered to offer patients the new VitalSight home blood pressure monitoring solution. Mount Sinai recently rolled out the VitalSight program to support the needs ofits patients with hypertension.

Browse 26 Market Data Tables and 26 Figures spread through 135 Pages and in-depth TOC on “Global Ambulatory Blood Pressure Monitors Market”- Forecast to 2030,  Global Ambulatory Blood Pressure Monitors Market, By Product Type (Wrist Monitors and Arm Monitors ), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)  

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/ambulatory-blood-pressure-monitors-market-411

Key Takeaways of the Global Ambulatory Blood Pressure Monitors Market:

• Global ambulatory blood pressure monitors market is expected to exhibit a CAGR of 8.4% during the forecast period. The Rising prevalence of hypertension and technological advancements in ambulatory blood pressure monitors are driving the market growth over the forecast period.
• Among Region, the Asia Pacific is expected to have highest CAGR in the global ambulatory blood pressure monitors market during the forecast perioddue to increasing prevalence of hypertension.  According to data published by Springer Nature Limited in December 5, 2023, in Japan, more than 100,000 people die annually from hypertension-related diseases.
• The major players operating in the global ambulatory blood pressure monitors market are OSI Systems Inc., SunTech Medical Inc., Andon Health Co. Ltd., Schiller AG, Omron Healthcare Co. Ltd., Beurer GmBH, Finapres Medical Systems B.V., Welch Allyn, Inc., Koninklijke Philips N.V., Aktiia, Biobeat, LiveMetric, and CardiAI Inc.